- Home
- CME vs TOVX Comparison
CME vs TOVX Comparison
Compare CME & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CME
- TOVX
- Stock Information
- Founded
- CME 1898
- TOVX 2001
- Country
- CME United States
- TOVX United States
- Employees
- CME N/A
- TOVX N/A
- Industry
- CME Investment Bankers/Brokers/Service
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- CME Finance
- TOVX Health Care
- Exchange
- CME Nasdaq
- TOVX Nasdaq
- Market Cap
- CME 99.3B
- TOVX 3.8M
- IPO Year
- CME 2002
- TOVX 2006
- Fundamental
- Price
- CME $275.08
- TOVX $0.50
- Analyst Decision
- CME Hold
- TOVX Hold
- Analyst Count
- CME 15
- TOVX 1
- Target Price
- CME $262.13
- TOVX N/A
- AVG Volume (30 Days)
- CME 2.6M
- TOVX 183.1K
- Earning Date
- CME 07-23-2025
- TOVX 08-12-2025
- Dividend Yield
- CME 3.92%
- TOVX N/A
- EPS Growth
- CME 13.21
- TOVX N/A
- EPS
- CME 9.94
- TOVX N/A
- Revenue
- CME $6,274,100,000.00
- TOVX N/A
- Revenue This Year
- CME $9.26
- TOVX N/A
- Revenue Next Year
- CME $4.04
- TOVX N/A
- P/E Ratio
- CME $27.67
- TOVX N/A
- Revenue Growth
- CME 11.73
- TOVX N/A
- 52 Week Low
- CME $193.17
- TOVX $0.40
- 52 Week High
- CME $290.79
- TOVX $7.37
- Technical
- Relative Strength Index (RSI)
- CME 50.11
- TOVX 45.57
- Support Level
- CME $271.56
- TOVX $0.42
- Resistance Level
- CME $277.90
- TOVX $0.48
- Average True Range (ATR)
- CME 4.48
- TOVX 0.03
- MACD
- CME 0.24
- TOVX 0.02
- Stochastic Oscillator
- CME 41.85
- TOVX 88.67
About CME CME Group Inc.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.